How Histogenics Corp (HSGX) Stacks Up Against Its Peers

As industrywide interest jumped, key hedge funds have been driving this bullishness. Perceptive Advisors assembled the biggest position in Histogenics Corp (NASDAQ:HSGX). Perceptive Advisors had $5.7 million invested in the company at the end of the quarter. Steven Boyd’s Armistice Capital also made a $0.9 million investment in the stock during the quarter. The only other fund with a brand new HSGX position is Efrem Kamen’s Pura Vida Investments.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Histogenics Corp (NASDAQ:HSGX) but similarly valued. These stocks are Gevo, Inc. (NASDAQ:GEVO), Connecture Inc (NASDAQ:CNXR), inTEST Corporation (NASDAQ:INTT), and MIND C.T.I. Ltd. (NASDAQ:MNDO). This group of stocks’ market caps resemble HSGX’s market cap.

As you can see these stocks had an average of 3.75 hedge funds with bullish positions and the average amount invested in these stocks was $4 million. That figure was $9 million in HSGX’s case. Connecture Inc (NASDAQ:CNXR) is the most popular stock in this table. On the other hand inTEST Corporation (NASDAQ:INTT) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Histogenics Corp (NASDAQ:HSGX) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and invested more capital in its shares, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None